.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...
.Our company currently recognize that Takeda is hoping to discover a path to the FDA for epilepsy me...
.Immunology biotech VBI Vaccinations is actually turning hazardously close to the climax, along with...
.It is actually hard to muscle mass in on a room as affordable as immunology, however Celldex Rehabs...
.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and a preclinical invuln...
.Ventyx Biosciences' Crohn's condition medication did certainly not assist clients achieve remission...
.Cognition Therapies' phase 2 SHINE trial has actually taken a few of the luster off the Alzheimer's...
.Bristol Myers Squibb has actually had a whiplash change of heart on its own BCMA bispecific T-cell ...
.Charles Baum, M.D., Ph.D., that looked after Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squ...
.After communicating to much more than 200 providers to companion a Tourette syndrome therapy that p...